Trade ENGN anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
enGene Therapeutics Inc. (ENGN) is trading at US$1.83, down 4.45% today as of Aug 28, 12:44 EDT. The company has a market capitalisation of US$119.24M. Over the past 52 weeks, ENGN has traded between US$1.40 and US$12.25. On Syfe you can trade ENGN with $0 commission and add it to your watchlist.
| Previous close | US$1.91 |
|---|---|
| Market cap | US$119.24M |
| 52-week range | US$1.40 – US$12.25 |
| Volume | 251.11K |
| Exchange | US |
Add to Watchlist
Set Price Alert
enGene Therapeutics Inc.
enGene Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24, 2023 and is headquartered in Saint-Laurent, Canada.
Year: 2023
Sector Update: Healthcare Stocks Decline Late Afternoon
Jun 18, 7:32 PM · MT Newswires
EnGene Shares Fall After Morgan Stanley Downgrade
Jun 18, 7:10 PM · MT Newswires
enGene Detalimogene's Durability Profile 'Not Competitive,' Morgan Stanley Says
Jun 18, 12:45 PM · MT Newswires
Morgan Stanley Downgrades enGene to Underweight From Equalweight
Jun 18, 10:18 AM · MT Newswires
UBS Adjusts enGene Price Target to $2 From $9, Maintains Neutral Rating
May 14, 12:53 PM · MT Newswires
enGene Therapeutics Inc. (ENGN) stock is trading at US$1.83, -4.45% from the previous close of US$1.91.
The market cap for enGene Therapeutics Inc. (ENGN) stock is approximately US$119.24M.
The 52-week high for enGene Therapeutics Inc. (ENGN) stock is US$12.25.
The 52-week low for enGene Therapeutics Inc. (ENGN) stock is US$1.40.
enGene Therapeutics Inc. (ENGN) does not currently pay a dividend.
Stay on top of ENGN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
